Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Advocates often emphasize the opportunity for meaningful therapeutic gains, principally in diseases where conventional therapies have proven limited. However, this is to assess the significant financial burden associated with CPI stem cell therapy